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Pcdh19 Loss-of-Function Increases 
Neuronal Migration In Vitro but is 
Dispensable for Brain Development 
in Mice
Daniel T. Pederick1,2, Claire C. Homan1,2, Emily J. Jaehne3, Sandra G. Piltz1,2, Bryan P. Haines1,2, 
Bernhard T. Baune3, Lachlan A. Jolly2,3, James N. Hughes1,2, Jozef Gecz1,2,3 & Paul Q. Thomas1,2
Protocadherin 19 (Pcdh19) is an X-linked gene belonging to the protocadherin superfamily, whose 
members are predominantly expressed in the central nervous system and have been implicated in cell-
cell adhesion, axon guidance and dendrite self-avoidance. Heterozygous loss-of-function mutations 
in humans result in the childhood epilepsy disorder PCDH19 Girls Clustering Epilepsy (PCDH19 GCE) 
indicating that PCDH19 is required for brain development. However, understanding PCDH19 function in 
vivo has proven challenging and has not been studied in mammalian models. Here, we validate a murine 
Pcdh19 null allele in which a β-Geo reporter cassette is expressed under the control of the endogenous 
promoter. Analysis of β-Geo reporter activity revealed widespread but restricted expression of PCDH19 
in embryonic, postnatal and adult brains. No gross morphological defects were identified in Pcdh19+/β-Geo 
and Pcdh19Y/β-Geo brains and the location of Pcdh19 null cells was normal. However, in vitro migration 
assays revealed that the motility of Pcdh19 null neurons was significantly elevated, potentially 
contributing to pathogenesis in patients with PCDH19 mutations. Overall our initial characterization 
of Pcdh19+/β-Geo, Pcdh19β-Geo/β-Geo and Pcdh19Y/β-Geo mice reveals that despite widespread expression 
of Pcdh19 in the CNS, and its role in human epilepsy, its function in mice is not essential for brain 
development.
Protocadherins comprise a large family of single pass transmembrane glycoproteins that have important roles in 
cell-cell adhesion, dendrite self-avoidance and axon guidance. In mammals, ~70 protocadherin genes have been 
identified, the majority of which are located in three genomic “clusters” termed α , β and γ . The remainder, termed 
“non-clustered protocadherins” are scattered throughout the genome and are classified as δ 1, δ 2 and “other”. Non- 
clustered protocadherins are widely expressed in the central nervous system and have been implicated in homo-
typic cell adhesion, neuronal migration and synaptic plasticity1–4.
Pcdh19 is an X-chromosome linked member of the δ 2 protocadherin subfamily and is highly expressed in the 
developing mouse cortex and hippocampus5. PCDH19 is highly conserved across human, mouse, zebrafish and 
chicken and has weak homotypic cell adhesion properties. It has been shown to interact with N-cadherin and 
members of the WAVE complex (Nap1 and Cyfip2) suggesting a role in actin cytoskeletal dynamics6,7. Genetic 
disruption of the closely related Pcdh10 or Pcdh17 genes (members of the δ 2 subfamily) in mice have revealed 
roles in axon extension, regulation of presynaptic assembly and growth of striatal axons and thalamocortical 
projections8–10. These studies raise the possibility Pcdh19 functions similarly during mouse brain development; 
however this remains unexplored due to the lack of a validated Pcdh19 null mouse.
The majority of studies investigating the endogenous role of Pcdh19 have been performed in zebrafish11–13. 
These studies have utilized either morpholino knockdown or mutation of Pcdh19 with each approach producing 
different phenotypes. Morpholino knockdown results in a severe phenotype where cell motility in the neural 
plate is compromised resulting in a severe disruption to early brain morphogenesis13. In contrast, pcdh19 null 
zebrafish generated by TALEN-induced frame-shift mutation are viable and fertile, and exhibit disruption of 
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columnar architecture in the optic tectum resulting in impaired visually guided behaviours12. While these data 
support a role for pcdh19 in cell-cell recognition during zebrafish brain development, the discordance between 
the mutant and morphant phenotypes, which is commonly observed in zebrafish14, makes interpretation of these 
data difficult.
In humans, heterozygous PCDH19 mutations cause PCDH19 GCE5,15 which is now recognized as the sec-
ond most common cause of monogenic epilepsy16. Mutations of PCDH19 that cause PCDH19 GCE are mainly 
missense, however as some cases have complete gene deletions, all pathogenic mutations are almost certainly 
loss-of-function. The phenotype of PCDH19 GCE is variable – affected girls present with symptoms ranging from 
benign focal epilepsy with normal cognitive function to severe seizures and intellectual disability that resemble 
Dravet syndrome16,17. The inheritance pattern of PCDH19 GCE is highly unusual for an X-linked gene, and is 
described as X-linked dominant with male sparing i.e. heterozygous females are affected whereas hemizygous 
males are not. Due to random X-chromosome inactivation affected females are composed of a mosaic population 
of normal and PCDH19 mutant cells. Intriguingly, rare cases of affected males have also been described, which 
arise from somatic mutation and also display mosaicism5,18. It has been proposed that the mosaicism of normal 
PCDH19 and mutant expressing cells leads to ‘scrambling’ of the neuronal circuitry in the brain of affected indi-
viduals. However, experimental support for this ‘cellular interference’ model remains limited.
Here we investigate the in vivo expression and function of Pcdh19 using mutant mice where the Pcdh19 gene is 
disrupted by a β-galactosidase-neomycin (β-Geo) reporter cassette. At this allele, β-Geo was expressed under the 
control of the endogenous Pcdh19 promoter, whilst Pcdh19 expression itself was ablated (i.e. a knock-out allele). 
Using β-Geo expression and X-Gal staining we show that Pcdh19 expression is widely expressed in the develop-
ing CNS through to adulthood. Although brain morphology in Pcdh19Y/β-Geo, Pcdh19β-Geo/β-Geo and Pcdh19+/β-Geo 
mutants appears grossly normal, in vitro analysis indicates that Pcdh19 null neurons have a slight but signifi-
cant increase in motility. These data suggest more subtle roles for Pcdh19 beyond establishment of gross brain 
architecture.
Results
Generation and validation of a Pcdh19 null mouse model. The Pcdh19 gene contains six exons, 
with exon 1 encoding the majority of the protein including the entire extracellular and transmembrane domains 
(Fig. 1A). To investigate the physiological role of Pcdh19 and the molecular pathology of PCDH19 GCE, we 
acquired a Pcdh19 null mouse model in which exons 1–3 were replaced with a β-geo cassette (Fig. 1B). Removal of 
the first 3 exons leads to deletion of both the extracellular and transmembrane domains of PCDH19. The genetic 
disruption of Pcdh19 gene was validated by PCR of genomic DNA (Fig. 1C) and ablation of Pcdh19 expression 
confirmed by qPCR of 2 week old hippocampal cDNA (Supplementary Fig. 1).
Figure 1. Generation of Pcdh19 Null Mice. (A) Pcdh19 contains 6 exons. Exon 1 encodes more than half 
of the protein including the entire extracellular domain and transmembrane domain. (B) Pcdh19 null mice 
were generated by Taconic through targeted homologous recombination. Exon 1, 2 and 3 were removed and 
replaced with a β-Galactosidase-Neomycin fusion cassette. (C) PCR was used to confirm the presence 
of the β -Galactosidase/Neomycin fusion cassette with primers P1, P2 and P3 (black arrowheads in B). The 
β-Galactosidase-Neomycin fusion cassette was only present in Pcdh19+/β-Geo and Pcdh19Y/β-Geo mice.
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Previous in situ hybridisation analysis has demonstrated Pcdh19 expression in the hippocampus and cortex of 
postnatal mouse brains5. However, expression of endogenous PCDH19 protein has not been shown. To investigate 
this issue, we performed western blot analysis using a commercially available PCDH19 antibody. Consistent with 
mRNA expression data, robust expression was observed in the hippocampus and cortex (Fig. 2A).
Integration of the β-geo cassette into the Pcdh19 locus potentially provides a reporter allele for null cells that 
would normally express Pcdh19. To confirm the activity of the β-geo cassette, X-Gal staining was performed on 
brain tissue from Pcdh19Y/β-Geo, Pcdh19+/β-Geo and Pcdh19+/Y mice. Pcdh19Y/β-Geo brains exhibit positive staining in 
multiple brain regions including the hippocampus, cortex and cerebellum (Fig. 2B) which is consistent with west-
ern blot analysis (Fig. 2A) and previously published RNA expression data5. Pcdh19+/β-Geo brains showed staining 
in the same brain regions but exhibited a mosaic staining pattern (Fig. 2B). Pcdh19+/Y brains showed no staining. 
This confirms the β-Geo cassette is active and that Pcdh19 undergoes random X-inactivation across multiple 
tissues similar to results in humans19.
Chemical fractionation of adult hippocampal samples revealed that PCDH19 was present within the syn-
aptosome, providing evidence for a role in synaptic function (Fig. 3A). Importantly, no signal was detected in 
Pcdh19Y/β-Geo samples, further confirming PCDH19 loss-of-function in this KO mouse model. Furthermore over-
expression of FLAG tagged human PCDH19 (PCDH19-FLAG) in primary hippocampal mouse neurons revealed 
PCDH19 localisation with SYNAPSIN further supporting PCDH19 expression in synapses (Fig. 3B).
Pcdh19+/β-Geo, Pcdh19β-Geo/β-Geo and Pcdh19Y/β-Geo Mice have No Gross Phenotypic Abnormalities. 
Breeding of the Pcdh19 mouse model generated Pcdh19+/β-Geo, Pcdh19β-Geo/β-Geo and Pcdh19Y/β-Geo mice at the 
expected frequencies (Supplementary Fig. 2). Adult mice with these genotypes had normal body size and did 
not exhibit any overt health issues (data not shown). To date, spontaneous seizures have not been detected in 
Pcdh19+/β-Geo, Pcdh19β-Geo/β-Geo or Pcdh19Y/β-Geo mice after weaning (ie. from 3 weeks of age).
Morpholino knock-down of pcdh19 in zebrafish embryos results in profound CNS abnormalities. We there-
fore examined gross brain morphology in Pcdh19 null mice. Histological analysis of Pcdh19+/β-Geo, Pcdh19β-Geo/β-Geo 
Figure 2. Validation of Pcdh19 Null mice. (A) Protein extracts from hippocampus, cortex and cerebellum 
brain regions were immunoblotted with PCDH19 antibody. PCDH19 was detected in wild type extracts but 
was absent from Pcdh19Y/β-Geo extracts. (B) Frozen sections from the same regions as A) were stained for 
β-Galactosidase activity using X-Gal. Staining was present in both Pcdh19+/β-Geo and Pcdh19Y/β-Geo brain  
sections but absent from wild type brain sections. Scale bar represents 250 μ m.
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and Pcdh19Y/β-Geo brains showed no gross morphological abnormalities (Fig. 4A). As Pcdh19 is highly expressed in 
the hippocampus and cortex, we performed morphometric analysis of these regions to determine if more subtle 
defects may be present. Measurements were made of the cortical thickness and CA1 region of the hippocampus 
with no significant difference observed in Pcdh19+/β-Geo, Pcdh19β-Geo/β-Geo and Pcdh19Y/β-Geo adult brains compared 
with Pcdh19+/+ and Pcdh19Y/+controls (Fig. 4B). We therefore conclude that mutation of Pcdh19 in mice does not 
overtly affect brain structure.
Pcdh19 Null Cells are Located Normally in the Developing and Adult Brain. Previous studies in 
zebrafish have shown that morpholino knockdown of Pcdh19 results in severe disruption of brain morphogenesis 
due to an arrest of cell convergence in the anterior neural plate as well as abnormal cell migration during neurula-
tion11,13, although this was not seen in pcdh19 null zebrafish12. To investigate whether mutation of Pcdh19 in mice 
affects neuronal migration during brain development we looked for ectopic localisation of β-Geo positive cells in 
developing (15.5 dpc) brains of Pcdh19+/β-Geo and Pcdh19Y/β-Geo mice using X-gal staining. As the Pcdh19-specific 
antibody used for western blot analysis was not compatible with immunohistochemistry (data not shown), wild 
type Pcdh19-expressing cells were identified by in situ hybridisation. At 15.5 dpc, robust Pcdh19 expression was 
detected in the developing cortex and hippocampus of Pcdh19Y/+brains (Fig. 5A). Wild type Pcdh19-expressing 
cells were also present in the cortex and hippocampus of Pcdh19+/β-Geo brains, although these were fewer in num-
ber consistent with X-inactivation (Fig. 5B). Importantly, analysis of Pcdh19Y/β-Geo and Pcdh19+/β-Geo embryonic 
brains revealed β-Geo-positive cells throughout the cortex and hippocampus in the same regions as wild type 
Pcdh19 expressing cells (Fig. 5E,F). To confirm that the different methods used to detect Pcdh19 expressing and 
mutant cells did not confound the analysis we performed in situ hybridisation of 15.5 dpc brains with a β-Geo 
probe (Supplementary Fig. 3). Cells expressing β-Geo were identified in the cortex and hippocampus as expected 
including the marginal zone, intermediate zone and ventricular/sub-ventricular zones (Fig. 5G). Taken together, 
these data suggest that mutant cells are not ectopically positioned in Pcdh19+/β-Geo and Pcdh19Y/β-Geo embryonic 
brains.
Given that Pcdh19 expression is maintained after birth5, we next investigated whether β-Geo expressing cells 
were ectopically expressed in Pcdh19+/β-Geo and Pcdh19Y/β-Geo brains at postnatal day 42 (P42). Consistent with 
our western blot analysis (Fig. 2A), robust expression of Pcdh19 was detected in the hippocampus and cortex of 
Pcdh19 WT brains (Fig. 6A). Pcdh19 expression was strongest in the CA1 and dentate gyrus of the hippocampus 
and in layers 2/3 and 5 of the cortex. Mosaic expression was identified in the same regions of Pcdh19+/β-Geo brains 
(Fig. 6B).
β-Geo staining of Pcdh19Y/β-Geo brains with X-Gal revealed robust expression in the cortex and hippocam-
pus that resembled the pattern of Pcdh19 expression in Pcdh19+/Y brains (Fig. 6). Mosaic expression of β-Geo 
was observed in these regions in Pcdh19+/β-Geo brains (Fig. 6E). No evidence of ectopic β-Geo-positive cells was 
detected. Thus, it appears that the mutation of Pcdh19 does not perturb positioning of neurons in postnatal brain 
development.
Figure 3. PCDH19 is expressed in the synapses of hippocampal neurons. (A) Synaptosome fractionation 
of P14 mouse hippocampus was performed and immunoblotted for PCDH19. PCDH19 protein was present in 
the synaptosome fraction which was also enriched for the synapse proteins PSD95 and SYNAPTOPHYSIN. 
PCDH19 was absent from all Pcdh19Y/β-Geo fractions. (B) Primary neurons were harvested from 18.5 dpc hippocampi 
and nucleofected with PCDH19-FLAG ORF. Immunostaning at DIV12 shows PCDH19 is colocalised with 
SYNAPSIN positive synapses. Scale bar represents 20 μ m.
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The Migration Potential of Pcdh19 Null Neurons is Increased In Vitro. As subtle defects in neuronal 
migration can be difficult to detect in vivo, we next performed in vitro migrations assays using neurospheres 
generated from Pcdh19 WT and Pcdh19 null embryos. Neural progenitor cells were isolated from the developing 
cortex (14.5 dpc) and cultured as non-adherent neurospheres. To model neuronal migration, whole neurospheres 
were adhered to a poly-L-lysine substrate and the migration of neurons outward from the neurosphere boundary 
measured20. Increased neuronal migration in the Pcdh19 null neurons was observed, as shown by an increase in 
the percentage of migrating neurons in the outer migration regions (bins) (Fig. 7A,B). However, this only reached 
significance in 4/9 of the bins. This data suggests that the mutant cells may have a subtle change in neuronal 
migration potential that does not translate into overt positional changes of neurons in the developing and adult 
mouse brain.
Discussion
Mutations of protocadherin genes in humans have been implicated in several neurological diseases and in mice 
have revealed important functions in neuronal development including axon guidance, neural circuit formation 
and synaptogenesis. Here we performed validation and gross morphological characterization of Pcdh19 null mice 
to determine the function of Pcdh19 in vivo.
Previous studies indicate that Pcdh19 expression is temporally and spatially restricted within the embryonic 
and neonatal CNS5,21. Using in situ hybridization and β-Geo reporter activity, we have shown that Pcdh19 expres-
sion is maintained in the adult brain. Expression was particularly robust in regions of the brain that are implicated 
in epilepsy including the hippocampus and in the cortex, where it was restricted to layers 2/3 and 5, although 
expression in other areas such as the cerebellum and the hypothalamus was also evident. We have attempted 
to further characterize endogenous PCDH19 CNS protein expression by immunohistochemistry using several 
commercially available PCDH19 antibodies, however none bind specifically to PCDH19 as evident by the immu-
nostaining patterns that were indistinguishable between Pcdh19 WT and Pcdh19 null brain sections (our unpub-
lished data). The β-Geo reporter gene in our Pcdh19 null mouse therefore provides a useful alternative method for 
identification of cells that normally express Pcdh19, especially given that loss of Pcdh19 function does not overtly 
affect neuron localization in vivo (see below).
Expression of Pcdh19 in the adult brain also raises the question of its subcellular localization. Using chemical 
fractionation and primary hippocampal neuron culture, we have shown that PCDH19 is located within both the 
synaptosome fraction in vivo and synapses in vitro suggesting it has synaptic function. Consistent with these 
results, analysis of chick PCDH19 in the optic tectum revealed substantial overlap with the synaptic marker 
Figure 4. Histological and morphometric analysis of adult Pcdh19 mutant mouse brains. (A) Haematoxylin 
and Eosin staining was performed on coronal P42 brain sections. Scale bar represents 1 mm. (B) Thickness 
measurement of the lateral parietal association cortex and hippocampus CA1 region in WT and Pcdh19 mutant 
brains. Three animals were analysed for each genotype. Error bars = SEM.
www.nature.com/scientificreports/
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Syntaxin7. Interestingly, Pcdh17, the closest related family member to Pcdh19, has recently been shown to play a 
role in synapse formation and synaptic vesicle assembly in murine corticobasal ganglia9. These data raise the pos-
sibility that PCDH19 may perform a similar function in vivo and supports the hypothesis that abnormal synaptic 
communication between PCDH19 WT and PCDH19 mutant cells contributes to the pathobiology of PCDH19 
GCE5.
Previous reports have shown that morpholino knockdown or genetic mutation of pcdh19 in zebrafish resulted 
in contrasting phenotypes11–13. In agreement with mutation of pcdh19 in zebrafish by Cooper et al. we show here 
that Pcdh19Y/β-Geo, Pcdh19β-Geo/β-Geo and Pcdh19+/β-Geo mice are healthy, fertile and do not exhibit gross defects 
in brain morphology. These striking phenotypic differences in zebrafish may reflect lack of genetic compensa-
tion in response to acute morpholino Pcdh19 knockdown in zebrafish which has been shown to account for 
similar differences in other studies22. In humans, hemizygous males do not exhibit intellectual disability or sei-
zures indicating that brain development occurs relatively normally without PCDH19, perhaps due to functional 
compensation by other PCDH19 family members23. The absence of morphological defects in Pcdh19Y/β-Geo and 
Pcdh19β-Geo/β-Geo mice is therefore not unexpected and suggests that Pcdh19 functional redundancy also occurs in 
mice. In contrast, the majority of PCDH19 heterozygous human females develop infantile seizures with variable 
cognitive defects, although there is no evidence of gross morphological defects affected individuals. It has been 
proposed that this phenotype results from “cellular interference” i.e. segregation of PCDH19 expressing neurons 
and PCDH19 mutant neurons in the developing brain development resulting in abnormal neural circuitry5,23. 
While there is little in vivo data to support this model, it is interesting to note that cortical dysplasia and cluster-
ing of dysplastic pyramidal neurons has been detected in a single female with PCDH19 GCE15. Although we did 
not detect any evidence of cortical dysplasia or gross abnormalities in Pcdh19+/β-Geo mice, we cannot exclude the 
possibility that subtle regionally-restricted defects may be present. Ryan et al. also detected dysplastic pyramidal 
cells ectopically positioned in the deep white layer, suggesting defective neuronal migration. To investigate this 
phenotype in Pcdh19+/β-Geo mice, we determined the location of Pcdh19 null cells using X-Gal staining in both 
developing and postnatal Pcdh19+/β-Geo brains. However, no evidence of ectopic Pcdh19 null cells was detected 
indicating that PCDH19 is not critical for neuronal cell migration in vivo. In contrast, a modest but significant 
increase in migration was detected in Pcdh19 null neurons generated from neurosphere explants. It is therefore 
possible that loss of Pcdh19 function compromises the migration potential of some neurons but that this defect is 
subtle and not associated with overt morphological defects in vivo.
Figure 5. Pcdh19 null cells are not ectopically located in the developing brain (15.5 dpc). (A–C) Pcdh19 WT 
cells were detected by in situ hybridisation and were located in the cortex and hippocampus of Pcdh19Y/+ 
(A) and Pcdh19+/β-Geo (B) developing brains. Pcdh19+/β-Geo brains exhibited less extensive staining consistent with 
X-inactivation. No specific signal was detected in Pcdh19Y/β-Geo brains (C). (D–F) Pcdh19 null cells were detected 
by X-Gal staining and were located in the cortex and hippocampus of Pcdh19+/β-Geo (E) and Pcdh19Y/β-Geo  
(F) developing brains. Pcdh19+/β-Geo brains showed reduced staining consistent with X-inactivation. No signal 
was detected in Pcdh19Y/+brains (D). Scale bar represents 500 μ m. Three animals were analysed for each 
genotype and age. (G) Pcdh19 null cells are predominantly located in the ventricular zone (VZ)/subventricular 
zone (SVZ), the intermediate zone (IZ) and the marginal zone (MZ). Scale bar represents 100 μ m.
www.nature.com/scientificreports/
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In summary, our characterization of Pcdh19 null mice reveals that Pcdh19 is widely expressed in the CNS 
but not required for brain development per se. However, given the significantly increased motility of Pcdh19 null 
neurons in vitro and the identification of Pcdh19 mutant phenotypes in other species, further detailed analysis of 
this mouse model may reveal subtle abnormalities in Pcdh19 null brains.
Methods
Animals. Pcdh19 null mice (TF2108) were purchased from Taconic Biosciences. Both male and female ani-
mals were used in this study. The day the vaginal plug was detected was designated as embryonic day 0.5 (0.5 dpc). 
The day of birth was designated postnatal day 0 (P0). Each group subjected to analysis contained at least three 
mice. All of the experiments were approved by The University of Adelaide Animal Ethics Committee and per-
formed according to their ethical guidelines.
Genotyping. Genotyping was performed by PCR amplification using three primers: one primer com-
mon to both Pcdh19 WT and Pcdh19 null alleles F-5′ -AGTCCACTACCGACTCTGCTG -3′ , one specific to 
the Pcdh19 WT allele R-5′ -CAAAGTTAGCCAGGCGGGAC-3′ and one specific to the Pcdh19 null allele R-5′ 
-AACTCACAACGTGGCACTGG-3′ . PCR products were separated on a 1% agarose gel. Pcdh19 WT and null 
allele products were 102 bp and 471 bp, respectively.
Protein extraction, synaptosome fractionation and western blotting. Cortex, hippocampi and 
cerebellum for protein extraction were minced in extraction buffer (50 mM Tris, 150 mM NaCl, 1% NP40 (Roche) 
and 1% Triton X-100 (Sigma) and incubated at 4 degrees C for 30 minutes. Synaptosome fractions were isolated 
using Syn-PER synaptic protein extraction reagent (ThermoFisher Scientific) according to the manufacturer’s 
instructions. Lysates and fractions were separated on Invitrogen Bolt™ precast 4–12% polyacrylamide gels and 
transferred to PVDF membrane before being blotted. Antibodies and their corresponding dilutions were: mouse 
anti-PCDH19 1:100 (Abcam, ab57510) and rabbit anti-β -ACTIN 1:1000 (Cell Signalling Technology, #4967), 
mouse anti-PSD95 1:2000 (ThermoScientific, 7E3-1138) and rabbit anti-SYNAPTOPHYSIN 1:5000 (Abcam, 
ab32127). Membranes were blocked in 5% BSA+5% Skim milk in Tris-buffered saline+0.1% Tween 20 (TBST) and 
antibodies were incubated with the membrane in 5% BSA in TBST. Membranes were developed using Bio-Rad 
Clarity Western ECL substrate and imaged using a Bio-Rad ChemiDoc.
Figure 6. Pcdh19 null cells are not ectopically located in the adult brain. (A–C) Pcdh19 WT cells were detected 
by in situ hybridisation and were located in the cortex and hippocampus of Pcdh19Y/+(A) and Pcdh19+/β-Geo  
(B) adult (P42) brains. Pcdh19+/β-Geo brains exhibited less staining consistent with X-inactivation. No specific signal 
was detected in Pcdh19Y/β-Geo brains (C). (D–F) Pcdh19 null cells were detected by X-Gal staining and were located 
in the cortex and hippocampus of Pcdh19+/β-Geo (E) and Pcdh19Y/β-Geo (F) adult brains. Pcdh19+/β-Geo brains showed 
less staining consistent with X-inactivation. No signal was detected in Pcdh19Y/+brains (D). Scale bar represents 
500 μ m. Three animals were analysed for each genotype and age. (G) Pcdh19 null cells are predominantly expressed 
in layer II/III and V of the adult cortex. Scale bar represents 100 μ m.
www.nature.com/scientificreports/
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Primary Hippocampal Neuron Culture, Nucleofection and Immunohistochemistry. 18.5 dpc 
hippocampi were dissected from wild type embryos and neurons dissociated with 0.5% Trypsin. 1 × 105 neurons 
were nucleofected with 1 μ g PCDH19-FLAG using the Neon Transfection System (Invitrogen) and seeded onto 
poly-D-lysine coated coverslips. Primary neurons were maintained in Neurobasal medium+B27 supplement (Life 
Technologies). Primary neurons were cultured for 12 days then fixed in 4% PFA for 15-30 minutes. For immu-
nofluorescence, cells were block permeablised with 0.1% Tween20 (PBST) and 10% foetal calf serum for 1 hour 
at room temperature. Primary neurons were then incubated overnight with anti-FLAG (1:1000, Sigma Aldrich) 
and anti-SYNAPSIN (1:500, Millipore) at 4˚C and then with secondary antibody (donkey anti-mouse Cy3 and 
donkey anti-rabbit Cy5; JacksonImmunoResearch). Images were acquired on a Nikon Eclipse Ti microscope.
X-gal staining. 15.5 dpc embryonic heads and dissected P42 brains were fixed in 4% paraformaldehyde at 
4 °C, cryoprotected in 30% sucrose and frozen in OCT embedding medium. Embryos were fixed in 4% paraform-
aldehyde in PBS. Whole embryos or cryosections were incubated in staining solution: 19 mM Sodium dihydro-
gen phosphate, 81 mM Disodium hydrogen phosphate, 2 mM MgCl2, 5 mM EGTA, 0.01% Sodium deoxycholate, 
0.02% NP-40, 5 mM Potassium ferricyanide, 5 mM Potassium ferrocyanide, and 1 mg/ml X-gal substrate, at 37 °C 
until blue staining was sufficient. Images were acquired on a Nikon Eclipse Ti microscope, compiled and mini-
mally processed (adjusted for color and light/dark) using Adobe Photoshop CS.
Histological analysis. Embryos for histological examination were fixed in 4% PFA, embedded in paraffin, 
cut at 5μ m and stained with Mayer’s haematoxylin and Eosin using standard approaches. Images were acquired 
on a Nikon Eclipse Ti Microscope and measurements taken using Nikon Imaging Software (NIS Elements). 
Three animals were analysed for each genotype with cortical measurements being made in the visual cortex and 
hippocampal measurements in the CA1 region. A total of ten measurements for each region was recorded for 
each individual animal and averaged. The mean was then determined from the average of the three animals in 
each group.
Figure 7. Loss of Pcdh19 leads to an increase in neuronal migration. Neural progenitor cells (NPCs) were 
isolated from the telencephalic vesicles of Pcdh19 WT or Pcdh19 null E14.5 embryos and grown as non-
adherent neurospheres. Neurospheres were plated on a Poly-L-Lysine substrate and cells were allowed to attach 
and migrate. (A) Neuronal migration was scored at 48 hrs by co-staining with a neuronal specific antibody β -III 
Tubulin (Cyan) and DAPI. (B) Neuronal migration was determined by drawing concentric circles around the 
contiguous boundary of the neurosphere and counting the number of neurons within each circle. Differences 
in the number of migrating neurons was determined by the percentage of neurons within each circle (bin). 
The percentage of neurons is greater in the more distal circles in the KO Pcdh19 neurospheres compared to 
the WT Pcdh19 neurospheres. Each data point represents 7 embryos collected from 3 litters with at least 20 
neurospheres scored for each embryo. Error bars = SEM, * differs from WT; P < 0.05, Student’s T-test.
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In situ hybridisation. 15.5 dpc embryonic heads and dissected P42 brains were fixed in 4% paraformal-
dehyde at 4 °C, cryoprotected in 30% sucrose and frozen in OCT embedding medium. In situ hybridization of 
16-μ M sections was performed as described previously24. The Pcdh19 probe was a digoxigenin-labeled antisense 
RNA probe prepared as described21. The LacZ probe sequence (500 bp) was generated by PCR using the follow-
ing primers F-5′ -ATGTGCGGCGAGTTGCGTGA-3′ R-5′ -CGCTCATCGCCGGAGCCAGC-3′ . At least three 
independent samples of each group were analyzed and representative sections are shown. No signal was detected 
using a sense control probe. Images were acquired on a Nikon Eclipse Ti microscope, compiled and minimally 
processed (adjusted for color and light/dark) using Adobe Photoshop CS.
Neurosphere Migration Assay. NPCs were isolated from the 14.5 dpc embryonic mouse cortex (telen-
cephalic vesicles) and grown as non-adherent neurospheres in the presence of 20 ng/mL bFGF and EGF as pre-
viously described25. Passage 4 neurospheres were cultured for 5 days and seeded onto a poly-L-lysine substrate 
at a density of 100 neurospheres/9.5 cm2 with the removal of growth factors. Cells were allowed to migrate for 
48 hrs before being fixed in 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) for 15 minutes at 
room temperature. For immunofluorescence analysis, cells were block permeablised in 0.2% tween20 (PBST) 
and 5% horse serum for 1 hour at room temperature. To identify neurons, cells were stained overnight with β -III 
tubulin primary antibody (1:300, Sigma Aldrich) in PBST with 0.5% horse serum at 4 °C and then with second-
ary antibody, donkey anti-mouse AlexaFluor647 (1:700, Invitrogen) for 1 hr at room temperature. Cells were 
counterstained with 300 nM 4′ ,6-diamidino-2-phenylindole (DAPI) to identify single cells and mounted with 
Slow-fade mounting media (Invitrogen) for microscopy. Fluorescence was viewed using the Zeiss AxioImager 
M2 fluorescent microscope (Carl Zeiss, Germany). Images of isolated single neurospheres and migrating cells 
were captured at 20× magnification using an Axiocam Mrm camera and Vs4.9.1.0 software (Axiovision, Carl 
Zeiss). Neurospheres were reconstructed using the Image J Stitching plugin26 and migration analysis preformed 
using the ImageJ2 software27. Briefly, the neurosphere boundary was identified and the radius of the neurosphere 
determined. The concentric circles plugin was used to draw 10 concentric circles (ie. migration zones) around the 
boundary of the sphere, with an outer radius calculated by the radius of the neurosphere+600 pixels (307 μ M). 
Using the cell counter plugin the number of migrating neurons within each concentric circle was determined by 
counting co-stained β -III tubulin and DAPI cells. The migration distance was then calculated as a percentage of 
total migrating cells within each circle (bin). Each data point represents 7 embryos collected from 3 litters with 
at least 20 neurospheres scored for each embryo. Analysis conducted by Student’s two-tailed, unpaired t test, 
assuming equal variance.
Real time PCR. RNA was extracted from P14 hippocampi by using an RNeasy mini column (Qiagen) 
according to the manufacturer’s instructions. Reverse transcription was performed on 1μ g of RNA using 
a High Capacity RNA to cDNA synthesis kit (Life Technologies). Real time PCR was performed on a Step 
One Plus thermocycler (Life Technologies) using Fast Sybr green master mix (Life Technologies) accord-
ing to manufacturer’s instructions on a two-step program. Primers and product sizes were as follows; Pcdh19 
(130 bp) F-5′ -TGGCAATCAAATGCAAGCGT-3′ R-5′ ACCGAGATGCAATGCAGACA-3′ , β -Galactosidase 
(85 bp) F-5′ TACGATGCGCCCATCTACAC-3′ R5′ AACAACCCGTCGGATTCTCC-3′ β -actin (89 bp) 
F-5′ -CTGCCTGACGGCCAGG-3′ R-5′ -GATTCCATACCCAAGAAGGAAGG-3′ .
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